Australian Operations
   
Include All CSL Behring Country Sites
Our Products
We develop and manufacture plasma protein biotherapies. These products help treat and prevent a range of human medical conditions. Read more.
Features
Plasma Derived Therapies
CSL commenced plasma fractionation for Australia in 1952. Today, CSL Behring Australia continues to be the chosen ...
News
CSL Renames its Australian Operations - CSL Behring & bioCSL
05-Dec-2012
Reorganisation of CSL Biotherapies into two ...